The establishment of a cell strain expressing HIV Vpr and the study on Vpr induced apoptosis

Chinese Journal of Microbiology and Immunology

Volumn 28, Issue 6, 2008, Pages 545-549

  Ding, Pei Pei ^a   Zheng, Yu Huang ^a   Gong, Guo Zhong ^a   Chen, Zi ^a   Zhou, Hua Ying ^a   Zhang, Chun Ying ^a   Liu, Meng ^a   Liu, Chun ^a   Yuan, Hong Li ^a   Li, Ying ^a   Li, Hui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Human immunodeficiency virus; Mutation; Transfection; Vpr gene

Indexed keywords

EID: 84863229154     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 2006, 33(6): 379-382.
2. Somasundaran M, Sharkey M, Brichacek B, et al. Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci USA, 2002, 99(14): 9503-9508.
3. Lum J J, Cohen O J, Nie Z, et al. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest, 2003, 111(10): 1547-1554.
4. Mazzucchelli R, Corvasce S, Violin M, et al. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals. J Biol Regul Homeost Agents, 2001, 15(3): 265-271.
5. Zhang H W, Qiu Z F, Li T S, et al. HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients. Zhonghua Yi Xue Za Zhi, 2004, 84(23): 1973-1976.
6. + T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity. Hum Immunol, 2001, 62(6): 561-576.
7. Rodes B, Toro C, Paxinos E, et al, Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS, 2004, 18(8): 1109-1116.
8. Jian H, Zhao L J. Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64. J Biol Chem, 2003, 278(45): 44326-44330.
9. Gaynor C. Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein. Exp Cell Res, 2001, 267(2): 243-257.
10. Fischer A, Lejczak C, lambert C, et al. Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection? AIDS, 2004, 18(9): 1346-1347.
11. Green D R, Kroemer G. The pathophysiology of mitochondrial cell death. Science, 2004, 305(5684): 626-629.
12. Brenner C, Kroemer G. The mitochondriotoxic domain of Vpr determines HIV-1 virulence. J Clin Invest, 2003, 111(10): 1455-1457.
13. Cavert W, Webb C H, Balfour H H Jr. Alterations in the C-termi-nal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy. J Infect Dis, 2004, 189(12): 2181-2184.
14. Serio D, Rizvi T A, Cartas M, et al. Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication. Proc Natl Acad Sci USA, 1997, 94(7): 3346-3351.
15. Cartas M, Singh S P, Serio D, et al. Intravirion display of a peptide corresponding to the dimer structure of protease attenuates HIV-1 replication. DNA Cell Biol, 2001, 20(2): 797-805.